Search Results 891-900 of 12834 for risksas

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care Jan. · Mayo Clinic Minute: Rainbows Cancer Clinic helps the ...

  2. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    HER2-positive breast cancer: What is it? Infographic: Breast Cancer Risk · Lumpectomy · Modified radical mastectomy · Nipple changes · Paulas story A team ...

  4. ACORYS-AI4AF a Pilot Study - Mayo Clinic

    The purpose of this study is to develop and evaluate the capacity of novel artificial intelligence models (i.e. ACORYS-AI4AF model) to predict post-ablation ...

  5. A Study To Evaluate The Effect Of GBT440 On Oxygenation In Healthy Subjects, Both At Rest And At Maximal Exercise - Mayo Clinic

    The purpose of this study is to evaluate the effects of GBT440 on the body and oxygen saturation levels , assessed at rest and at maximum exercise under ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    HER2-positive breast cancer: What is it? Infographic: Breast Cancer Risk · Lumpectomy · Modified radical mastectomy · Nipple changes · Paulas story A team ...

  7. HT-3951 vs. Placebo in Stroke Rehabilitation - Mayo Clinic

    About this study. This is a randomized, double-blind, placebo-controlled parallel group outpatient study that will utilize standard stroke rehabilitation ...

  8. Seizures - Doctors and departments - Mayo Clinic

    Watch Mayo Clinic doctors discuss epilepsy diagnosis, treatment and research on YouTube. Mayo Clinic experts trained in neurology, neurosurgery and other areas ...

  9. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    HER2-positive breast cancer: What is it? Infographic: Breast Cancer Risk · Lumpectomy · Modified radical mastectomy · Nipple changes · Paulas story A team ...